BOCCHIO CHIAVETTO, LUISELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.583
EU - Europa 6.861
AS - Asia 1.588
AF - Africa 262
SA - Sud America 141
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 5
Totale 17.462
Nazione #
US - Stati Uniti d'America 8.444
RU - Federazione Russa 3.383
DE - Germania 1.495
CN - Cina 736
UA - Ucraina 608
SG - Singapore 605
GB - Regno Unito 345
SE - Svezia 285
IT - Italia 240
CM - Camerun 236
FR - Francia 155
FI - Finlandia 134
CA - Canada 122
BR - Brasile 102
IE - Irlanda 95
TR - Turchia 88
PL - Polonia 84
VN - Vietnam 42
IN - India 31
EU - Europa 22
HK - Hong Kong 16
EC - Ecuador 13
ES - Italia 10
IL - Israele 10
MX - Messico 10
ZA - Sudafrica 8
BD - Bangladesh 7
ID - Indonesia 7
PE - Perù 7
SA - Arabia Saudita 7
AR - Argentina 6
CO - Colombia 5
IR - Iran 5
MA - Marocco 5
HU - Ungheria 4
JP - Giappone 4
PK - Pakistan 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AU - Australia 3
BE - Belgio 3
KE - Kenya 3
LT - Lituania 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
GR - Grecia 2
IQ - Iraq 2
JO - Giordania 2
KZ - Kazakistan 2
MY - Malesia 2
NL - Olanda 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
BB - Barbados 1
BF - Burkina Faso 1
BJ - Benin 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
GP - Guadalupe 1
HN - Honduras 1
HT - Haiti 1
IS - Islanda 1
KI - Kiribati 1
KR - Corea 1
KY - Cayman, isole 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 17.462
Città #
Fairfield 1.564
Ashburn 701
Woodbridge 699
Seattle 696
Houston 661
Beijing 640
Cambridge 604
Jacksonville 560
Chandler 539
Wilmington 504
Moscow 304
Ann Arbor 213
Dallas 185
Singapore 184
London 145
The Dalles 110
Ottawa 106
Boardman 103
Chicago 95
Naples 93
Dublin 92
Lawrence 90
Princeton 86
New York 76
Kraków 65
Helsinki 64
Rome 61
San Diego 49
Saint Petersburg 35
Los Angeles 34
Frankfurt am Main 31
Portsmouth 28
Yubileyny 25
Lauterbourg 19
Nanjing 17
Norwalk 16
Prescot 16
Ho Chi Minh City 15
Hong Kong 15
San Francisco 14
Cedar Knolls 13
Kunming 13
Redwood City 13
Chiswick 12
Guangzhou 12
Warsaw 11
Düsseldorf 10
Hanoi 10
Milan 10
Mumbai 10
Hefei 9
Islington 9
Kilburn 9
Roubaix 9
São Paulo 9
Atlanta 8
Dearborn 8
Hounslow 8
Mexico City 8
Falls Church 7
Johannesburg 7
Mcallen 7
Wroclaw 7
Boston 5
Brooklyn 5
Chengdu 5
Council Bluffs 5
Guayaquil 5
Nanchang 5
Quito 5
Redmond 5
St Louis 5
St Petersburg 5
Stockholm 5
Bexley 4
Guarulhos 4
New Bedfont 4
Rio de Janeiro 4
Santa Clara 4
Shanghai 4
Toronto 4
West Jordan 4
Ankara 3
Brussels 3
Caxias do Sul 3
Chennai 3
Istanbul 3
Jinan 3
Kansas City 3
Kocaeli 3
Manchester 3
Munich 3
Nairobi 3
Porto Alegre 3
Redondo Beach 3
Rimini 3
Riyadh 3
Segrate 3
Shenyang 3
Sotto 3
Totale 9.914
Nome #
The -1727 A/T, -50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms and resistance to antipsychotics in schizophrenia 580
Immune and metabolic alterations in first episode psychosis (FEP) patients 373
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 325
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 286
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients 283
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects 283
Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis 282
Allelic variation in the human prodynorphin gene promoter and schizophrenia 265
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients 255
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. 252
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease 251
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 249
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease 249
Effetti biomolecolari del maltrattamento infantile: il ruolo dell'epigenetica e dell'infiammazione 246
Aspetti biologici e neuropsicologici del maltrattamento e abuso infantili 245
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 242
Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: A case-control study 238
BDNF Val66Met polymorphism and protein levels in Amniotic Fluid 236
Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients 232
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses 230
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 230
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia 227
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence 227
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 226
Glucose metabolism alterations in patients with bipolar disorder 226
Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs 224
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16 222
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia 221
Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study 221
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients 220
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. 219
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 218
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 218
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 214
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 212
Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor 211
Blood microRNA changes in depressed patients during antidepressant treatment 210
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 210
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 209
Blood microRNA longitudinal changes in depressed patients during antidepressant treatment 208
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment 208
Season of birth and inflammatory response system in schizophrenia 205
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients 205
Markers of Alzheimer's disease in a population attending a memory clinic 204
Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study 202
Effects of Intranasal Oxytocin on Long-Term Memory in Healthy Humans: A Systematic Review 199
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 199
G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 198
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter 197
Lack of association between MnSOD gene polymorphism and sporadic Alzheimer's disease 197
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 197
VEGF serum levels in depressed patients during SSRI antidepressant treatment 196
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 194
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 194
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases 190
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics 190
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 188
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 184
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 182
No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects 173
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants 169
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 159
Association study of-1727 A/T,-50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms with schizophrenia 153
Association between IL-1 cluster and IL-10 gene polymorphisms and schizophrenia 151
Association study and meta-analysis of-308 A/G functional polymorphism in TNF alpha gene with schizophrenia 150
Gene-environment interaction in major depression: focus on experience-dependent biological systems 150
Association between IL-1 beta-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia 150
CYP2D6 polymorphism in patients with Alzheimer's disease in treatment with cholinesterase inhibitors 147
Association study between -1727A/T, -50C/T and (CAA)(N) repeat GSK-3beta gene polymorphisms and Bipolar Disorder 146
Influence of G1730A polymorphism of estrogen receptor beta gene on brain morphology in postmenopausal women 142
The cytokine network genes and resistance to antipsychotics in schizophrenia 140
Peripheral BDNF levels and personality traits in a sample of subjects non affected by psychiatric diseases 137
Evidence in Support of the AD Biomarker Dynamic Model from a Memory Clinic Naturalistic Series of Patients with Mild Cognitive Impairment 135
Childhood trauma and glucose metabolism in patients with first-episode psychosis 134
Serum brain derived neurotrophic factor concentrations in attention deficit hyperactivity disorder (ADHD) 133
Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive state 130
Serum and plasma BDNF levels in major depression: Replication study plus meta-analysis 128
miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity 123
Myeloid microvesicles in CSF are associated with myelin damage and neuronal loss in mild cognitive impairment and alzheimer disease. 120
Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study 116
Molecular mechanisms of brain stimulation. (Chapter 11). 112
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 108
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 103
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup. 87
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 86
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations 78
Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients 72
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 66
P.264 Association of single nucleotide polymorphisms in the 3’ untranslated region of SLC1A2 with major depressive disorder and relative endophenotypes 62
Vascular endothelial growth factor (VEGF) serum: putative predictive biomarkers for the electroconvulsive therapy (ECT) in depressed patients 59
Reduction of oxytocin plasma levels in borderline personality disorder and normalization induced by psychotherapies 40
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients 26
Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of "Psychobiotics" 23
null 5
null 2
null 1
null 1
null 1
Totale 17.622
Categoria #
all - tutte 90.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.950 0 0 0 400 288 243 322 142 125 116 247 67
2021/2022598 108 59 128 46 9 21 21 139 33 23 8 3
2022/20231.614 176 11 11 221 167 344 1 230 299 43 87 24
2023/2024558 27 40 62 68 59 86 21 10 0 16 5 164
2024/20254.245 34 22 18 3 113 319 2.282 779 302 62 183 128
2025/2026796 181 102 371 142 0 0 0 0 0 0 0 0
Totale 17.622